Samle, telle, regne, fortolke – tilbakeblikk på Kreftregisterets statistikkproduksjon og forskning gjennom 70 år
DOI:
https://doi.org/10.5324/nje.v30i1-2.4989Abstract
The Cancer Registry of Norway was established 1952 with important initiatives and impetus from WHO and The Norwegian Cancer Society. The main purpose of the Registry has been to describe and explain trends and frequencies in cancer incidence, to analyse the need for cancer prevention and therapy, inclusive of aetiological research, and to study the effects of cancer control. The first report on cancer incidence covering 1953–1954 was published in 1959. In the 1950s, stomach cancer was the most common cancer among men and women combined, breast cancer was the most frequent cancer in women, and lung cancer was rising in men (observed in the mortality rates). Identification and the full understanding of different aspects of smoking and cancer remained a challenge from the 1950s through the 1980s, nationally and internationally. From 1977 to 1989, the Cancer Registry produced incidence reports every year with tables presenting absolute numbers and crude rates. In the 1990s, age-standardisation appeared in routine data, both in national, county, and historical rates. During the initial decades, important scientific support was received from Denmark, UK and the USA. Nordic co-operation has always been vital for exchange of experience, for comparisons, and for addressing rare cancer forms. Studies of occupational cancer emerged from the early 1970s, starting with nickel refiners and asbestos cement workers. The number of scientific publications and defended doctoral theses rose markedly during the 1990s and after, with projects directed towards aetiology (lifestyle, medication, occupation, environmental exposures), early diagnosis and screening, clinical issues, predictions, survival, biomarkers, and socio-economic factors.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Tom K. Grimsrud
This work is licensed under a Creative Commons Attribution 4.0 International License.
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).